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Summary 
Both, common gene variants and human adenovirus 36 (Adv36) 
are involved in the pathogenesis of obesity. The potential 
relationship between these two pathogenic factors has not yet 
been investigated. The aim of our study was to examine the 
association of obesity susceptibility loci with Adv36 status. 
Genotyping of ten gene variants (in/near TMEM18, SH2B1, 
KCTD15, PCSK1, BDNF, SEC16B, MC4R, FTO) and analysis of 
Adv36 antibodies was performed in 1,027 Czech adolescents 
aged 13.0-17.9 years. Variants of two genes (PCSK1 and BDNF) 
were associated with Adv36 seropositivity. A higher prevalence of 
Adv36 antibody positivity was observed in obesity risk allele 
carriers of PCSK1 rs6232, rs6235 and BDNF rs4923461 vs. non-
carriers (χ2=6.59, p=0.010; χ2=7.56, p=0.023 and χ2=6.84, 
p=0.033, respectively). The increased risk of Adv36 positivity  
was also found in PCSK1 variants: rs6232 (OR=1.67, 95 % CI 
1.11-2.49, p=0.016) and rs6235 (OR=1.34, 95 % CI 1.08-1.67, 
p=0.010). PCSK1 rs6232 and BDNF rs925946 variants were 
closely associated with Adv36 status in boys and girls, 
respectively (χ2=5.09, p=0.024; χ2=7.29, p=0.026). 
Furthermore, PCSK1 rs6235 risk allele was related to Adv36 
seropositivity (χ2=6.85, p=0.033) in overweight/obese subgroup. 
In conclusion, our results suggest that obesity risk variants of 
PCSK1 and BDNF genes may be related to Adv36 infection. 
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Introduction 
 
The prevalence of obesity in children and 
adolescents remains high despite numerous recent 
attempts to improve strategies in prevention and 
treatment (Ahluwalia et al. 2015, Ahrens et al. 2014). 
Novel insights into the multifactorial pathogenesis of 
obesity have, however, been made during the last decade. 
The genome-wide association study (GWAS) approach 
has identified a number of common variants related to 
body mass index (BMI) and obesity. Several associations 
have been replicated in various populations, including in 
children and adolescents (den Hoed et al. 2010, Nead et 
al. 2015). A total of 97 gene variants (56 novel) were 
described by the latest GWAS in 2015 (Locke et al. 
2015). Variations have been mostly found in or near 
unknown genes whose function and impact on body 
weight regulation still need to be elucidated (Locke et al. 
2015). The role of human adenovirus 36 (Adv36) in the 
pathogenesis of obesity was first documented in 
experimental animal models (Dhurandhar et al. 2000). 
Adv36 infection induces adipogenesis by promoting 
proliferation and differentiation of preadipocytes and by 
increasing lipid accumulation in adipocytes (Pasarica et 
al. 2008). An association of Adv36 with increased body 
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weight in humans has clearly been confirmed over the 
last decade (Aldhoon-Hainerova et al. 2014, Atkinson et 
al. 2005, Shang et al. 2014). An important role of genetic 
factors in susceptibility to various infectious diseases has 
been demonstrated by family studies and multiple GWAS 
(Chapman and Hill 2012). Additionally, an impaired 
immunity in obesity (Tanaka et al. 1993) leads to 
a greater susceptibility to different infections (Karlsson et 
al. 2010). If the pathogenesis of obesity is partly 
mediated by infectious agents we may speculate whether 
there is a relationship between obesity susceptibility gene 
loci and Adv36 infection.  
The aim of our study was to investigate the 
association of ten previously reported gene variants 
associated with BMI and obesity with Adv36 
seropositivity and their relation to gender and body 
weight in Czech adolescents. 
 
Methods 
 
Subjects 
A study population consisted of 1,027 Czech 
adolescents aged 13.0-17.9 years (476 boys and 551 girls; 
of them 540 were normal weight and 487 
overweight/obese) who were selected from the original 
Childhood Obesity Prevalence and Treatment project 
(Aldhoon-Hainerova et al. 2014). Only those with 
complete data on anthropometric parameters, genotypes 
and Adv36 antibody assessment were included in the 
present study. All participants and their parent(s) signed 
an informed consent before the initiation of study 
procedures. The study protocol was approved by the 
Ethical Committee of the Institute of Endocrinology in 
Prague and was in accordance with the Helsinki 
declaration II. 
  
Anthropometric assessment 
Body height, body weight, BMI and its z-score 
were assessed as described previously (Aldhoon-
Hainerova et al. 2014). Overweight and obesity was 
defined as BMI ≥ 90th percentile according to the Czech 
BMI references specified for sex and age (Kobzova et al. 
2004).  
 
Genotyping 
Ten single nucleotide polymorphisms (SNPs) – 
rs7561317 (transmembrane protein 18 gene, TMEM18), 
rs7498665 (SH2B adaptor protein 1 gene, SH2B1), 
rs29941 (potassium channel tetramerisation domain 
containing 15 gene, KCTD15), rs6232 and rs6235 
(proprotein convertase subtilisin/kexin type 1 gene, 
PCSK1), rs925946 and rs4923461 (brain-derived 
neurotrophic factor gene, BDNF), rs10913469 (SEC16 
homolog B S. cerevisiae gene, SEC16B), rs17782313 
(melanocortin 4 receptor gene, MC4R) and rs9939609 
(fat mass and obesity associated gene, FTO) were 
studied. SNPs in both the PCSK1 (rs6232, rs6235) and 
the BDNF (rs925946, rs4923461) were analyzed 
separately due to their incomplete linkage (Dusatkova et 
al. 2013). Genotyping was performed using the TaqMan 
SNP Genotyping Assays (Applied Biosystems, Waltham, 
MA, USA) on a Biomark (Fluidigm, South San 
Francisco, CA, USA) and LightCycler 480 (Roche, 
Basel, Switzerland) and described in detail by Dusatkova 
et al. (2013). In the present study all SNPs followed the 
Hardy-Weinberg equilibrium (evaluated by chi-square 
test, p>0.05). 
 
Adv36 antibody assessment 
The detection of Adv36 antibodies from serum 
was done by a competitive enzyme-linked 
immunosorbent assay developed by Obetech, LLC 
(Richmond, VA, USA).  
 
Statistical analyses 
Characteristics of Adv36 negative and Adv36 
positive groups were compared using chi-squared test for 
descriptive variables and nonparametric Mann-Whitney 
test for quantitative variables (expressed as medians with 
lower and upper quartiles). Chi-squared tests and odds 
ratios (ORs) were calculated to determine associations of 
Adv36 seropositivity with genotypes and alleles, 
respectively. Analyses with genotypes were performed in 
the whole cohort as well as in subgroups stratified by 
gender and body weight. When the number of minor 
homozygotes was less than five, they were combined 
with heterozygotes for such a genotype. Statistical 
software NCSS 2004 (NCSS, LLC, Kaysville, UT, USA) 
was used. P-value (two-tailed) <0.05 was considered 
statistically significant. 
 
Results 
 
Of the total 1,027 adolescents, 26.4 % presented 
with positive Adv36 antibodies. The basic characteristics 
of the cohort based on Adv36 antibody status are shown 
in Table 1. A significantly higher prevalence of Adv36 
antibody positivity was found in girls as compared to 
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boys (Table 1). Genotype distributions and risk allele 
frequencies according to Adv36 status are presented in 
Table 2. Obesity risk allele carriers of PCSK1 rs6232, 
PCSK1 rs6235 and BDNF rs4923461 had significantly 
higher prevalence of Adv36 positivity than non-carriers 
(Table 2). Also the other BDNF variant rs925946 had 
a borderline association with Adv36 infection (Table 2). 
Furthermore, both minor alleles of PCSK1 increased 
chances of having positive Adv36 antibodies (Table 2). 
Analyses taking into account gender revealed a higher 
prevalence of Adv36 positivity in males carrying risk 
PCSK1 rs6232 (χ2=5.09, p=0.024) and in females 
carrying risk allele BDNF rs925946 (χ2=7.29, p=0.026). 
When stratified by body weight, the relation of PCSK1 
rs6235 with Adv36 was confirmed in the 
overweight/obese subgroup (χ2=6.85, p=0.033). 
 
 
Table 1. Characteristics of the study population according to the 
presence of Adv36 antibodies. 
 
Characteristics Adv36- Adv36+ p 
All (n=1027) 756 (73.6%) 271 (26.4%)  
Boys/girls 383/373 93/178 <0.001a 
Age (years) 15.7 (14.5; 16.8) 15.8 (14.7; 16.9) 0.445b 
BMI z-score 0.5 (-0.1; 2.6) 1.5 (0.1; 2.8) 0.027b 
Overweight 333 (44.1%) 154 (56.8%) <0.001a 
Boys (n=476) 383 (80.5%) 93 (19.5%)  
Age (years) 15.6 (14.4; 16.7) 15.9 (15.1; 16.9) 0.134b 
BMI z-score 0.5 (0; 2.6) 1.3 (0.1; 2.7) 0.227b 
Overweight 171 (44.7%) 50 (53.8%) 0.114a 
Girls (n=551) 373 (67.7%) 178 (32.3%)  
Age (years) 15.9 (14.8; 16.9) 15.7 (14.6; 17) 0.560b 
BMI z-score 0.5 (-0.1; 2.7) 1.6 (0; 2.8) 0.082b 
Overweight 162 (43.4%) 104 (58.4%) 0.001a 
 
Quantitative data are described as medians (lower; upper 
quartiles). a p-values were derived from chi-squared tests, b from 
Mann-Whitney tests. Adv36-, adenovirus 36 antibody negative; 
Adv36+, adenovirus 36 antibody positive; BMI, body mass index. 
 
 
Discussion 
 
Our association study of 1,027 Czech adolescents 
is the first to investigate the relationship between obesity 
susceptibility loci and Adv36 antibody status. As all 
identified GWAS loci are able to explain not more than 
2.7 % of variation in BMI and their predictive value is low 
(Locke et al. 2015), an elucidation of these mostly 
unknown genes in pathophysiology of obesity could be 
valuable. Of ten examined gene variants, variants of two 
genes showed some relation to the presence of Adv36 
antibodies. The obesity risk alleles rs6232 and rs6235 of 
PCSK1 and rs4923461 of BDNF were associated with 
a higher prevalence of Adv36 seropositivity in both 
genders regardless of body weight. The same tendency was 
observed for rs925946 of BDNF but only in girls. PCSK1 
encodes a protease from the subtilisin-like proprotein 
convertase family that process polypeptide hormones and 
neuropeptide precursors (Jansen et al. 1995). The rs6232 
variant encodes a substitution N221D that reduces catalytic 
activity of the protease and leads to obesity, while the 
rs6235 (S690T) had no effect on catalytic activity 
(Benzinou et al. 2008). BDNF, a member of the nerve 
growth factor family essential for survival of striatal 
neurons in the brain, is involved in hypothalamic 
regulation of energy balance through the leptin-
melanocortin signaling pathway (Nicholson et al. 2007). 
Both, rs4923461 and rs925946 are intergenic variants 
localized within the BDNF antisense non-coding transcript. 
It was shown that inhibition of this transcript upregulates 
BDNF mRNA (Modarresi et al. 2012), thus we could 
speculate that examined BDNF variants influence BDNF 
expression and consequently energy homeostasis. The 
minor allele of PCSK1 rs6235 was significantly more 
prevalent in Adv36 positive overweight/obese subgroup, 
but not in normal weight counterparts. In obese subjects, 
particularly in those extremely obese, a more severe course 
of infectious diseases has been shown (Almond et al. 2013, 
Garcia et al. 2015). An association between obesity risk 
alleles and Adv36 seropositivity may partly be due to 
a greater susceptibility of obese individuals to infection. In 
addition, the combined effect of Adv36 infection with 
obesity risk genotype in the development of obesity should 
also be considered. An expression of PCSK1 and BDNF is 
mainly situated to hypothalamic regions and mutations in 
these genes cause rare monogenic forms of early onset 
obesity (Hinney et al. 2014). The adipogenic effect of 
Adv36 studied in rats was also confirmed in the central 
nervous system (Pasarica et al. 2006). Moreover, Adv36 
reduces leptin production (Vangipuram et al. 2007). Until 
now we may only speculate if these gene variants influence 
the susceptibility to Adv36 infection and consequently 
body weight. Nevertheless, we would point out the 
important role of genetic susceptibility as well as the role 
of Adv36 infection in body weight regulation. The major 
limitation of our study is the size of our cohort, which may 
not be sufficiently powered to detect low effects of 
common gene variants. 
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Table 2. Associations of ten gene variants with the presence of Adv36 antibodies. 
 
Variant Genotypes (n) RAF (%) 
χ2 OR (95 % CI) 
p p 
TMEM18 rs7561317 AA AG GG G   
 Adv36- 13 202 541 84.9 3.17 0.79 (0.61; 1.03) 
 Adv36+ 7 85 179 81.7 0.205 0.095 
 SH2B1 rs7498665 AA AG GG G   
 Adv36- 254 375 127 41.6 3.74 1.11 (0.91; 1.35) 
 Adv36+ 91 121 59 44.1 0.154 0.338 
KCTD15 rs29941 AA AG GG G   
 Adv36- 72 339 345 68.1 1.17 0.94 (0.76; 1.15) 
 Adv36+ 32 117 122 66.6 0.557 0.571 
 PCSK1 rs6232 CC CT TT C   
 Adv36- 2 65 689 4.6 6.59 a 1.67 (1.11; 2.49) 
 Adv36+ 1 38 232 7.4 0.010 0.016 
PCSK1 rs6235 CC CG GG G   
 Adv36- 427 291 38 24.3 7.56 1.34 (1.08; 1.67) 
 Adv36+ 131 117 23 30.1 0.023 0.010 
BDNF rs925946 GG GT TT T   
 Adv36- 387 315 54 28.0 5.79 1.16 (0.93; 1.43) 
 Adv36+ 135 104 32 31.0 0.055 0.202 
BDNF rs4923461 AA AG GG A   
 Adv36- 484 225 47 78.9 6.84 1.17 (0.91; 1.50) 
 Adv36+ 176 89 6 81.4 0.033 0.247 
SEC16B rs10913469 CC CT TT C   
 Adv36- 24 233 499 18.6 0.21 1.05 (0.82; 1.35) 
 Adv36+ 10 85 176 19.4 0.899 0.735 
MC4R rs17782313 CC CT TT C   
 Adv36- 63 295 398 27.8 0.74 0.99 (0.80; 1.23) 
 Adv36+ 19 112 140 27.7 0.690 0.985 
 FTO rs9939609 AA AT TT A   
 Adv36- 162 385 209 46.9 2.20 1.16 (0.95; 1.41) 
  Adv36+ 68 138 65 50.6 0.333 0.157 
 
Chi-squared tests (χ2) were performed among genotypes, odds ratios (OR) between alleles. a Minor homozygotes and heterozygotes 
were combined. Adv36-, adenovirus 36 antibody negative; Adv36+, adenovirus 36 antibody positive; CI, confidence interval; RAF, risk 
allele frequency. 
 
 
In conclusion, our results suggest that obesity 
susceptibility loci of PCSK1 and BDNF genes may be 
related to the status of Adv36 antibodies and consequently 
to body weight. However, to validate our findings, further 
investigations in larger cohorts are required. 
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